Navigation Links
NewYork-Presbyterian/Weill Cornell physician-scientists present at 2010 American Urological Meeting
Date:6/2/2010

NEW YORK (May 29, 2010) -- Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center will present their latest research findings at the American Urological Association's Annual Meeting in San Francisco, May 29 to June 3.

Dr. Steven Kaplan, a urologist and professor of urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and Dr. Darracott Vaughan, senior author and professor emeritus of urology at Weill Cornell Medical College, have published data showing that 5-alpha reductase inhibitors (5-ARI), drugs used to control for benign prostatic hypertrophy (BPH), an enlarged prostate, may greatly improve the accuracy of traditional PSA tests for prostate cancer diagnosis.

"Taking 5-ARI drugs may eliminate the background noise associated with PSA testing -- canceling out a benign response and leaving only one signal for malignancy," explains Dr. Kaplan, lead author of the study. "Using PSA testing, we may now be able to distinguish prostate cancer from benign prostatic hyperplasia (BPH) disease."

Dr. Kaplan will present these potentially groundbreaking findings during a press briefing on June 1 at 1:00 p.m. PST and for meeting attendees on June 2 at 12:20 p.m. PST at Moscone North, 120 & 123.

Among the most significant presentations are the following.

  • Surgeons' robotic surgery experience has impact on surgical cancer margins and operative time [2023] Wednesday, June 2, 1:00 p.m. 3:00 p.m.; Moscone North, 130 & 131

    Dr. Ashutosh Tewari
    Director of Robotic Prostatectomy and Prostate Cancer-Urologic Oncology Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Tewari will present results from a multi-institutional study examining surgeons' robotic surgical experience. Recent media reports have raised concerns regarding training for robotic surgical procedures. The impact of experience is outlined in this study, demonstrating that greater surgical experience appears to be associated with a reduced percentage of positive surgical cancer margins and operative time after robot-assisted radical prostate removal.

  • Generic form of prostate enlargement drug shows fewer side effects [1786] Tuesday, June 1, 4:30 p.m. 4:40 p.m.; Moscone North, 120 & 123

    Dr. Alexis Te
    Director of the Brady Prostate Center and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Te will present results from a five-year study showing that generic, less-expensive drug for controlling prostate enlargement may produce fewer side-effects, such as erectile dysfunction, ejaculatory dysfunction, lowered libido and breast enlargement. The drugs 5alpha reductase inhibitors (5ARI) have been widely used in the management of men with benign prostatic hypertrophy (BPH). The study compared the generic finasteride and name brand dutasteride.

  • Fewer complications with laparoscopic kidney surgery compared with open [1482] Tuesday, June 1, 11:20 a.m. 11:30 a.m.; Moscone North, 122 & 125

    Dr. Douglas Scherr
    Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Associate Professor of Urology at Weill Cornell Medical College

    Dr. Scherr will present results showing that laparoscopic surgery has fewer complications than traditional open procedures for the treatment of kidney disease and cancer, such as lowered operative time during laparoscopic partial nephrectomy (LPN), less blood loss and shortened hospital stay.

  • New surgical modification for reduced incontinence following prostate removal [2029] Wednesday, June 2, 1:00 p.m. 3:00 p.m.; Moscone North, 130 & 131

    Dr. Ashutosh Tewari
    Director of Robotic Prostatectomy and Prostate Cancer-Urologic Oncology Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Tewari will present findings showing that a surgical modification called the anatomic retro-apical technique reduces incontinence following robotic prostate removal surgery. Incontinence is the most common side effect following prostate removal.


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Related medicine news :

1. National Center on Minority Health and Health Disparities awards $8 million to Weill Cornell
2. iTriage Mobile Healthcare Technology Presented in Washington, DC at the Community Health Data Forum
3. TransforMED's Delta-Exchange Teams with Group Practice Forum to Present Free Webinar Series on Diabetes Population Management
4. RockWest Technology Group Presents Campus Contactless Card Technology at NACCU
5. Choosing Representation Can Help Disability Applicants Avoid Long Lines at Social Security Offices
6. Academic Impacts of Concussions for Students at Issue in House of Representatives
7. NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day
8. Harmony Information Systems Selected to Present at Exclusive MAVA Capital Connection 2010 Event
9. Morehead Presents Webinar on “Creating a High-Performing RN Workforce”
10. Meharry Medical College President Testifies Before the U.S. House of Representatives
11. PSA-TEC to Present State of the Industry Panel Discussion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... accreditation with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading ... advanced care and patient safety. Only a few hospitals and facilities have earned ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... , ... December 08, 2016 , ... California Senate Bill ... payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical ... Institute (WCRI) . , According to the study, medical payments per claim in California ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance ... in Hamilton County, is embarking on a charity drive with the aim of ... homes for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec. 9, 2016  Forge Therapeutics, Inc. today ... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance ... the treatment of bacterial infections including those caused ... as an attractive antibacterial target for more than ... suitable chemical starting points has hampered its progress. ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Ophthalmic ... new report, "Australia Ophthalmic Lasers Market Outlook to 2022", ... market. The report provides value, in millions of US ... market segements - Excimer Lasers, Femtosecond Lasers and YAG ... distribution shares data for each of these market segements, ...
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... Patient warming ... of blood during surgeries, lowering the risks of neurological disorders ... of SSIs. The patient warming systems can be segmented into ... benefits in turn reduce the stay at hospitals thus, lowering ...
Breaking Medicine Technology: